Molecule enhances copper's lethal punch against microbes

July 31, 2014, Duke University Medical Center

Harnessing a natural process in the body that pumps lethal doses of copper to fungi and bacteria shows promise as a new way to kill infectious microbes, a team of scientists at Duke University report.

Publishing in the July 31, 2014, issue of the journal Chemistry & Biology, the researchers describe a way of exploiting the unique chemical response from the body's immune system to attack pathogens using , long known for its antimicrobial properties, in a way that minimizes harm to the rest of the body.

The findings in cell and animal models represent progress in developing broad-spectrum antimicrobial agents on the basis of copper biology – a much-needed advance in the face of escalating antibiotic resistance and lethal .

"There is a clear need for new strategies for antimicrobial therapies," said senior author Dennis J. Thiele, Ph.D., the George Barth Geller Professor
of Pharmacology and Cancer Biology and of Biochemistry at Duke University School of Medicine. "Copper, while essential, can be toxic when mismanaged by the body, but our work demonstrates that we can activate the metal's antimicrobial potential in a targeted fashion that focuses on the immune cells and avoids copper imbalance throughout the body."

Thiele, who has studied the biology of copper for more than 30 years, teamed with Katherine J. Franz, Ph.D., the Alexander F. Hehmeyer Associate Professor of Chemistry at Duke, to use a small molecule previously created in the Franz lab that essentially escorts additional copper to specialized chambers within immune cells called macrophages.

Faced with fungal or bacterial infections, macrophages ingest and attempt to destroy the pathogens by locking them in tiny death chambers and unleashing an oxidative burst of hydrogen peroxide, nitric oxide and other poisons, including copper. But both and bacteria deploy resistance mechanisms to the chemical onslaught in the macrophage compartments.

Thiele, Franz and colleagues used a clever chemical trick that takes advantage of this oxidative onslaught to unleash the active molecule selectively in the macrophage death chambers. The molecule then synergizes with copper already present in the cells to kill microbial pathogens. The strategy is designed to protect healthy cells by avoiding copper binding in cells that have not been infected.

"This provides a strategy for the development of compounds that exploit the activated immune response and override the copper detoxification machinery in fungal and bacterial pathogens to boost the body's own antimicrobial activity," Franz said.

Thiele said future studies will focus on enhancing the molecule's drug-like properties to optimize its ability to fight additional fungal and bacterial infections in animal models. They are also continuing to explore how the molecule works, and whether related molecules can deliver additional metal payloads, including silver, which also has .

Explore further: A bad penny: Cancer's thirst for copper can be targeted

Related Stories

A bad penny: Cancer's thirst for copper can be targeted

April 9, 2014
Drugs used to block copper absorption for a rare genetic condition may find an additional use as a treatment for certain types of cancer, researchers at Duke Medicine report.

Molecule regulates production of antibacterial agent used by immune cells

June 20, 2014
Researchers have discovered how a protein molecule in immune cells promotes the production of nitric oxide, a potent weapon in the cells' arsenal to defend the body from bacterial attack. The protein may offer a target for ...

Recommended for you

Precision neuroengineering enables reproduction of complex brain-like functions in vitro

November 14, 2018
One of the most important and surprising traits of the brain is its ability to dynamically reconfigure the connections to process and respond properly to stimuli. Researchers from Tohoku University (Sendai, Japan) and the ...

Gene mutation found to cause macrocephaly and intellectual deficits

November 13, 2018
The absence of one copy of a single gene in the brain causes a rare, as-yet-unnamed neurological disorder, according to new research that builds on decades of work by a University at Buffalo biochemist and his colleagues.

Can scientists change mucus to make it easier to clear, limiting harm to lungs?

November 12, 2018
For healthy people, mucus is our friend. It traps potential pathogens so our airways can dispatch nasty bugs before they cause harm to our lungs. But for people with conditions such as cystic fibrosis (CF) and chronic obstructive ...

Scientists uncover new gatekeeper function of anti-aging molecule

November 12, 2018
The protein klotho has been shown to promote longevity and counteract aging-related impairments. Having more klotho seems to allow for longer and healthier lives, whereas a depletion of this molecule accelerates aging and ...

Mutations, CRISPR, and the biology behind movement disorders

November 12, 2018
Scientists at the RIKEN Center for Brain Science (CBS) in Japan have discovered how mutations related to a group of movement disorders produce their effects. Published in Proceedings of the National Academy of Sciences, the ...

Researchers explain how your muscles form

November 12, 2018
All vertebrates need muscles to function; they are the most abundant tissue in the human body and are integral to movement.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.